Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
JAMA Intern Med
    July 2021
  1. STEINBROOK R
    The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.
    JAMA Intern Med. 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622
    >> Share

  2. DUNN B, Stein P, Cavazzoni P
    Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective.
    JAMA Intern Med. 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607
    >> Share

  3. MITCHELL SL, D'Agata EMC, Hanson LC, Loizeau AJ, et al
    The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
    JAMA Intern Med. 2021 Jul 12. pii: 2782003. doi: 10.1001/jamainternmed.2021.3098
    >> Share

    November 2020
  4. NICHOLAS LH, Langa KM, Bynum JPW, Hsu JW, et al
    Financial Presentation of Alzheimer Disease and Related Dementias.
    JAMA Intern Med. 2020 Nov 30. pii: 2773241. doi: 10.1001/jamainternmed.2020.6432
    >> Share

    December 2019
  5. BURKE JF, Langa KM
    Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-Reply.
    JAMA Intern Med. 2019;179:1737.
    >> Share

  6. RABINOVICI GD, Carrillo MC
    Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease.
    JAMA Intern Med. 2019;179:1736-1737.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016